MedPath

A clinical trial to evaluate the effect of an Ayurvedic medicine, varyadi kashaya in patients with raised blood levels of uric acid.

Phase 2
Conditions
Health Condition 1: M109- Gout, unspecified
Registration Number
CTRI/2023/03/050452
Lead Sponsor
INSTITUTE OF POST GRADUATE AYURVEDIC EDUCATION AND RESEARCH AT S.V.S.P.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENTS HAVING CLASSICAL SYMPTOMS OF VATARAKTA(GOUT) WILL BE SELECTED FROM OPD AND IPD.

TODA (PRICKING PAIN)

BHEDA (TEARING PAIN)

DAHA (BURNING SENSATION)

SUPTI (NUMBNESS)

SOPHA (SWELLING)

RAGA (REDNESS)

Exclusion Criteria

PATIENTS BELLOW 20 AND ABOVE 65 YEARS OF AGE.

PATIENTS WITH HEART DISEASE, MALIGNANCY, PREGNANT, SEVERE RENAL DISEASE, SEVERE HEPATIC DISEASE AND ANY OTHER CONDITION WHICH THE PRINCIPAL INVESTIGATOR THINKS MAY JEOPARDIZE THE STUDY.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MEAN PERCENTAGE DECREASE IN SERUM URIC ACID LEVEL FROM THE BASELINE TO THE END OF STUDY.Timepoint: DECREASE THE SERUM URIC ACID LEVEL AFTER 15 DAYS AND 30 DAYS OF TREATMENT.
Secondary Outcome Measures
NameTimeMethod
RELIEF IN THE CLINICAL SYMPTOMS OF VATARAKTA (GOUT) <br/ ><br>TODA (PRICKING PAIN) <br/ ><br>BHEDA (TEARING PAIN) <br/ ><br>DAHA (BURNING SENSATION) <br/ ><br>SUPTI (NUMBNESS) <br/ ><br>SOPHA (SWELLING) <br/ ><br>RAGA (REDNESS)Timepoint: UPTO 30 DAYS
© Copyright 2025. All Rights Reserved by MedPath